An earlier study for the same sample population reported a steep 45.3% BRCA1 mutation frequency in women diagnosed before the age of 50 years, 41% in women with a first-degree relative with breast or ovarian cancer and 58% in women with bilateral BC, concluding the need for genetic testing among BC patients in The Bahamas [88]. Here, BRCA1 is linked to ovarian carcinoma.